In today’s scientific landscape, artificial intelligence (AI) is revolutionising research methodologies and scientific writing, reshaping how we conduct and disseminate research. As AI’s presence grows, so do questions surrounding ethics, authenticity and the integrity of scientific publications. While AI brings benefits like efficiency and new ideas, it also brings challenges like bias and fake information.
Now, we wonder: what should, and shouldn’t we publish?
Join Dr Eric Rubin, Editor-in-Chief of the New England Journal of Medicine, and our esteemed host Professor Nick Fisk, Deputy Vice-Chancellor of Research & Enterprise, as they engage in an interactive interview on scientific integrity in health.
Our experts will offer invaluable insights into ethical considerations in AI-integrated research, explain what should not be published considering technological advancements, and pinpoint red flags to steer clear of in scientific literature.
This discussion aims to empower researchers and professionals to produce authentic work of the highest integrity.
Don't miss the chance to join UNSW Medicine & Health for an interview on the balance between innovation and integrity, and how to navigate AI's role in research and scientific literacy.
Eric Rubin is Editor-in-Chief of the New England Journal of Medicine. He earned an AB degree from Harvard College and MD and PhD degrees from Tufts University, did clinical training at the Massachusetts General Hospital and postdoctoral work at Harvard Medical School. He is an Adjunct Professor at the Harvard TH Chan School of Public Health where his lab studies tuberculosis. Eric also practices infectious disease at the Brigham and Women’s Hospital and is a Professor of Medicine at Harvard Medical School. He is a member of the American Academy of Microbiology, the American Association of Physicians and the National Academy of Medicine.
Professor Nicholas Fisk AM FAHMS FRSN MBBS DDU PhD CMFM MBA GAICD FRCOG FRANZCOG is the Deputy Vice-Chancellor (Research & Enterprise) at UNSW Sydney, where his portfolio is to optimise research performance, infrastructure and training along with securing external research investment, aligning with industry engagement, and promoting translational innovation, commercialisation and entrepreneurship. His background is as a clinical scientist in fetal medicine with his main research focus on perinatal stem cell biology and monochorionic intertwin transfusion with over 400 publications.
After training in Australia Nick spent two decades at Imperial College London before leadership roles at the University of Queensland. Nick has had several international and national leadership roles and current Board memberships include Research Australia, NewSouth Innovations, TEDi-London, SPHERE (the Sydney Partnership for Health, Education, Research and Enterprise) and Chair of the Go8 DVCR's Committee. Past roles include President of the International Fetal Medicine and Surgery Society, Chair of the Steering Committee of the Association of Academic Health Centers International, and Chair of the Go8 Deans of Medicine Committee. He has also served on the Boards of the Queensland Institute of Medical Research, the Metro North Hospital and Health Service, Paediatrio, and the Australian Housing and Urban Research Institute.
